1 Kim I, "Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells" 276 : 7614-7620, 2001a
2 Baumer S, "Vascular endothelial cell-specific phosphotyrosine phosphatase(VE-PTP) activity is required for blood vessel development" 107 : 4754-4762, 2006
3 Nawroth R, "VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts" 21 : 4885-4895, 2002
4 Asahara T, "Tie2 receptor ligands,angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization" 83 : 233-240, 1998
5 Wong AL, "Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues" 81 : 567-574, 1997
6 Cascone I, "Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1" 102 : 2482-2490, 2003
7 Hato T, "The role of angiopoietin-like proteins in angiogenesis and metabolism" 18 : 6-14, 2008
8 Duronio V, "The life of a cell: apoptosis regulation by the PI3K/PKB pathway" 415 : 333-344, 2008
9 Lomberk G, "The family feud: turning off Sp1 by Sp1-like KLF proteins" 392 : 1-11, 2005
10 Simon MP, "The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1" 217 : 809-818, 2008
1 Kim I, "Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells" 276 : 7614-7620, 2001a
2 Baumer S, "Vascular endothelial cell-specific phosphotyrosine phosphatase(VE-PTP) activity is required for blood vessel development" 107 : 4754-4762, 2006
3 Nawroth R, "VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts" 21 : 4885-4895, 2002
4 Asahara T, "Tie2 receptor ligands,angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization" 83 : 233-240, 1998
5 Wong AL, "Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues" 81 : 567-574, 1997
6 Cascone I, "Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1" 102 : 2482-2490, 2003
7 Hato T, "The role of angiopoietin-like proteins in angiogenesis and metabolism" 18 : 6-14, 2008
8 Duronio V, "The life of a cell: apoptosis regulation by the PI3K/PKB pathway" 415 : 333-344, 2008
9 Lomberk G, "The family feud: turning off Sp1 by Sp1-like KLF proteins" 392 : 1-11, 2005
10 Simon MP, "The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1" 217 : 809-818, 2008
11 Fiedler U, "The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies" 103 : 4150-4156, 2004
12 Scharpfenecker M, "The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism" 118 : 771-780, 2005
13 Batard P, "The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells" 87 : 2212-2220, 1996
14 Brindle NP, "Signaling and functions of angiopoietin-1 in vascular protection" 98 : 1014-1023, 2006
15 Atkins GB, "Role of Kruppel-like transcription factors in endothelial biology" 100 : 1686-1695, 2007
16 Audoy-Remus J, "Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2" 28 : 10187-10199, 2008
17 Suri C, "Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis" 87 : 1171-1180, 1996
18 Karpanen T, "Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling" 312 : 575-583, 2006
19 Hashiyama M, "Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells" 87 : 93-101, 1996
20 Saharinen P, "Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2" 169 : 239-243, 2005
21 Adams RH, "Molecular regulation of angiogenesis and lymphangiogenesis" 8 : 464-478, 2007
22 Lohela M, "Lymphangiogenic growth factors, receptors and therapies" 90 : 167-184, 2003
23 SenBanerjee S, "KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation" 199 : 1305-1315, 2004
24 Eliceiri BP, "Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis" 140 : 1255-1263, 1998
25 Parmar KM, "Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2" 116 : 49-58, 2006
26 Bhattacharya R, "Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2" 280 : 28848-28851, 2005
27 Peters KG, "Functional significance of Tie2 signaling in the adult vasculature" 59 : 51-71, 2004
28 Fachinger G, "Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2" 18 : 5948-5953, 1999
29 Xue Y, "FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue" 105 : 10167-10172, 2008
30 Brown LF, "Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma" 156 : 2179-2183, 2000
31 Kim I, "EphB ligand, ephrinB2, suppresses the" 16 : 1126-1128, 2002
32 Dumont DJ, "Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo" 8 : 1897-1909, 1994
33 Master Z, "Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak" 20 : 5919-5928, 2001
34 Sato TN, "Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation" 376 : 70-74, 1995
35 Fukuhara S, "Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1" 10 : 513-526, 2008
36 Chae JK, "Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization" 20 : 2573-2578, 2000
37 Witzenbichler B, "Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2" 273 : 18514-18521, 1998
38 고주영, "Biomedical significance of endothelial cell specific growth factor, angiopoietin" 생화학분자생물학회 34 (34): 1-11, 2002
39 Lee HJ, "Biological characterization of angiopoietin-3 and angiopoietin-4" 18 : 1200-1208, 2004
40 Fiedler U, "Angiopoietins: a link between angiogenesis and inflammation" 27 : 552-558, 2006
41 Saharinen P, "Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts" 10 : 527-537, 2008
42 Valenzuela DM, "Angiopoietins 3 and 4: diverging gene counterparts in mice and humans" 96 : 1904-1909, 1999
43 Xu Y, "Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis" 64 : 6119-6126, 2004
44 Maisonpierre PC, "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis" 277 : 55-60, 1997
45 Tressel SL, "Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis" 28 : 1989-1995, 2008
46 Fiedler U, "Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation" 12 : 235-239, 2006a
47 Fiedler U, "Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation" 12 : 235-239, 2006b
48 Gale NW, "Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1" 3 : 411-423, 2002
49 Jang C, "Angiopoietin-2 Exocytosis Is Stimulated by Sphingosine-1-Phosphate in Human Blood and Lymphatic Endothelial Cells" 2008
50 Kim I, "Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway" 86 : 24-29, 2000
51 Kim I, "Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression" 89 : 477-479, 2001b
52 Thurston G, "Angiopoietin-1 protects the adult vasculature against plasma leakage" 6 : 460-463, 2000
53 Gamble JR, "Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions" 87 : 603-607, 2000
54 Papapetropoulos A, "Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway" 275 : 9102-9105, 2000
55 Sako K, "Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2" 2008
56 Harfouche R, "Angiopoietin-1 activates both antiand proapoptotic mitogen-activated protein kinases" 17 : 1523-1525, 2003
57 Kanda S, "Angiopoietin 1 is mitogenic for cultured endothelial cells" 65 : 6820-6827, 2005
58 Carmeliet P, "Angiogenesis in life, disease and medicine" 438 : 932-936, 2005
59 Carmeliet P, "Angiogenesis in health and disease" 9 : 653-660, 2003
60 Gordon S, "Alternative activation of macrophages" 3 : 23-35, 2003
61 Manning BD, "AKT/PKB signaling: navigating downstream" 129 : 1261-1274, 2007
62 Jones N, "A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function" 23 : 2658-2668, 2003